Loading...
Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
Atrial fibrillation (AF) is strongly associated with cardioembolic stroke, and thromboprophylaxis is an established means of reducing stroke risk in patients with AF. Oral vitamin K antagonists such as warfarin have been the mainstay of therapy for stroke prevention in patients with AF. However, the...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3283221/ https://ncbi.nlm.nih.gov/pubmed/22355190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/europace/eur263 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|